Position in NTRA
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$254,348
New position
Shares Held
937
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#631
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Everhart Financial Group, Inc. holds $3,732,179 across 6 Diagnostics & Research names. NTRA ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
1,939 | $1,020,767 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,924 | $964,616 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
2,874 | $651,794 | |
| 4 | A |
Agilent Technologies, Inc.
|
3,706 | $492,267 | |
| 5 | DHR |
Danaher Corp /De/
|
1,829 | $348,387 | |
| 6 | NTRA |
Natera, Inc.
This page
|
937 | $254,348 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,348 | 937 | Shares | Sole | 2026-07-09 | |
| No filing history on record for this holder in this stock. | ||||||